Serotonin 5-HT7 receptor is critically involved in acute and chronic inflammation of the gastrointestinal tract

Inflammatory Bowel Diseases

Volumn 20, Issue 9, 2014, Pages 1516-1529

  Guseva, Daria ^a   Holst, Katrin ^a   Kaune, Beate ^a   Meier, Martin ^a   Keubler, Lydia ^a   Glage, Silke ^a   Buettner, Manuela ^a   Bleich, André ^a   Pabst, Oliver ^a   Bachmann, Oliver ^a   Ponimaskin, Evgeni G ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

5 HT7 receptor; Crohn's disease; Dendritic cells; DSS induced colitis; Intestinal inflammation

Indexed keywords

3 [2 [2 (4 METHYL 1 PIPERIDINYL)ETHYL] 1 PYRROLIDINESULFONYL]PHENOL; CD86 ANTIGEN; CD8ALPHA ANTIGEN; CXCL9 CHEMOKINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR RECEPTOR; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 3 RECEPTOR; INTERLEUKIN 6; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; SEROTONIN 7 RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; DEXTRAN SULFATE; IL10 PROTEIN, MOUSE; INTERLEUKIN 10; SEROTONIN; SEROTONIN RECEPTOR;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CELL COUNT; CELL DAMAGE; CELL INFILTRATION; CELL POPULATION; CELLS BY BODY ANATOMY; CHRONIC INFLAMMATION; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; CYTOKINE PRODUCTION; DEXTRAN SODIUM SULFATE-INDUCED COLITIS; DISEASE ACTIVITY; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERPLASIA; IN VIVO STUDY; INTESTINE WALL; LETHALITY; MALE; MIDDLE AGED; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURVIVAL RATE; THICKNESS; TISSUE INJURY; ULCER; YOUNG ADULT; ACUTE DISEASE; ADOLESCENT; ANIMAL; CHEMICALLY INDUCED; CHEMISTRY; CHRONIC DISEASE; COLITIS; DISEASE MODEL; DRUG EFFECTS; ENZYME IMMUNOASSAY; FOLLOW UP; GASTROINTESTINAL TRACT; GENETICS; INFLAMMATION; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; PHYSIOLOGY; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ACUTE DISEASE; ADOLESCENT; ADULT; ANIMALS; BLOTTING, WESTERN; CHRONIC DISEASE; COLITIS; CROHN DISEASE; DEXTRAN SULFATE; DISEASE MODELS, ANIMAL; FEMALE; FOLLOW-UP STUDIES; GASTROINTESTINAL TRACT; HUMANS; IMMUNOENZYME TECHNIQUES; INFLAMMATION; INTERLEUKIN-10; MALE; MICE; MICE, KNOCKOUT; MIDDLE AGED; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, SEROTONIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEROTONIN; YOUNG ADULT;

EID: 84907528634     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/MIB.0000000000000150     Document Type: Article

References (56)

1. Gershon MD. Serotonin and its implication for the management of irritable bowel syndrome. Rev Gastroenterol Disord. 2003;3:S25-S34.
2. Khan WI, Ghia JE. Gut hormones: emerging role in immune activation and inflammation. Clin Exp Immunol. 2010;161:19-27.
3. Wheatcroft J, Wakelin D, Smith A, et al. Enterochromaffin cell hyperplasia and decreased serotonin transporter in a mouse model of postinfectious bowel dysfunction. Neurogastroenterol Motil. 2005;17:863-870.
4. Belai A, Boulos PB, Robson T, et al. Neurochemical coding in the small intestine of patients with Crohn's disease. Gut. 1997;40:767-774.
5. Coates MD, Mahoney CR, Linden DR, et al. Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome. Gastroenterology. 2004;126:1657-1664.
6. Ghia JE, Li N, Wang H, et al. Serotonin has a key role in pathogenesis of experimental colitis. Gastroenterology. 2009;137:1649-1660.
7. Linden DR, Chen JX, Gershon MD, et al. Serotonin availability is increased in mucosa of guinea pigs with TNBS-induced colitis. Am J Physiol Gastrointest Liver Physiol. 2003;285:G207-G216.
8. Kordasti S, Sjovall H, Lundgren O, et al. Serotonin and vasoactive intestinal peptide antagonists attenuate rotavirus diarrhoea. Gut. 2004;53:952-957.
9. Wang H, Steeds J, Motomura Y, et al. CD4+ T cell-mediated immunological control of enterochromaffin cell hyperplasia and 5-hydroxytryptamine production in enteric infection. Gut. 2007;56:949-957.
10. Barnes NM, Sharp TA. A review of central 5-HT receptors and their function. Neuropharmacology. 1999;38:1083-1152.
11. Bockaert J, Claeysen S, Bécamel C, et al. Neuronal 5-HT metabotropic receptors: fine-tuning of their structure, signaling, and roles in synaptic modulation. Cell Tissue Res. 2006;326:553-572.
12. De Ponti F, Tonini M. Irritable bowel syndrome: new agents targeting serotonin receptor subtypes. Drugs. 2001;61:317-332.
13. Sanger GJ. 5-hydroxytryptamine and the gastrointestinal tract: where next? Trends Pharmacol Sci. 2008;29:465-471.
14. Hedlund PB, Sutcliffe JG. Functional, molecular and pharmacological advances in 5-HT7 receptor research. Trends Pharmacol Sci. 2004;25:481-486.
15. Prause AS, Stoffel MH, Portier CJ, et al. Expression and function of 5-HT7 receptors in smooth muscle preparations from equine duodenum, ileum, and pelvic flexure. Res Vet Sci. 2009;87:292-299.
16. Tonini M, Vicini R, Cervio E, et al. 5-HT7 receptors modulate peristalsis and accommodation in the guinea pig ileum. Gastroenterology. 2005;129: 1557-1566.
17. Zou BC, Dong L, Wang Y, et al. Expression and role of 5-HT7 receptor in brain and intestine in rats with irritable bowel syndrome. Chin Med J. 2007;120:2069-2074.
18. Leon-Ponte M, Ahern GP, O'Connell PJ. Serotonin provides an accessory signal to enhance T-cell activation by signaling through the 5-HT7 receptor. Blood. 2007;109:3139-3146.
19. Idzko M, Panther E, Stratz C, et al. The serotoninergic receptors of human dendritic cells: identification and coupling to cytokine release. J Immunol. 2004;172:6011-6019.
20. Müller T, Dürk T, Blumenthal B, et al. 5-hydroxytryptamine modulates migration, cytokine and chemokine release and T-cell priming capacity of dendritic cells in vitro and in vivo. PLoS One. 2009;4:6453.
21. Kuhn R, Lohler J, Rennick D, et al. Interleukin-10-deficient mice develop chronic enterocolitis. Cell. 1993;75:263-274.
22. Michael S, Keubler LM, Smoczek A, et al. Quantitative phenotyping of inflammatory bowel disease in the IL-10-deficient mouse by use of noninvasive magnetic resonance imaging. Inflamm Bowel Dis. 2013; 19:185-193.
23. Hume DA. Macrophages as APC and the dendritic cell myth. J Immunol. 2008;181:5829-5835.
24. Alex P, Zachos NC, Nguyen T, et al. Distinct cytokine patterns identified from multiplex profiles of murine DSS and TNBS-induced colitis. Inflamm Bowel Dis. 2009;15:341-352.
25. Herbrand H, Bernhardt G, Förster R, et al. Dynamics and function of solitary intestinal lymphoid tissue. Crit Rev Immunol. 2008;28:1-13.
26. Rochereau N, Verrier B, Pin JJ, et al. Phenotypic localization of distinct DC subsets in mouse Peyer Patch. Vaccine. 2011;29:3655-3661.
27. Stagg AJ, Hart AL, Knight SC, et al. The dendritic cell: its role in intestinal inflammation and relationship with gut bacteria. Gut. 2003;52:1522-1529.
28. Pils MC, Bleich A, Prinz I, et al. Commensal gut flora reduces susceptibility to experimentally induced colitis via T-cell-derived interleukin-10. Inflamm Bowel Dis. 2011;17:2038-2046.
29. Ng YL, Klopcic B, Lloyd F, et al. Secreted protein acidic and rich in cysteine (SPARC) exacerbates colonic inflammatory symptoms in dextran sodium sulphate-induced murine colitis. PLoS One. 2013;8:e77575.
30. Dinarello CA. Interleukin-18, a proinflammatory cytokine. Eur Cytokine Netw. 2000;11:483-486.
31. Bischoff SC, Mailer R, Pabst O, et al. Role of serotonin in intestinal inflammation: knockout of serotonin reuptake transporter exacerbates 2,4,6-trinitrobenzene sulfonic acid colitis in mice. Am J Physiol Gastrointest Liver Physiol. 2009;296:G685-G695.
32. Ahern GP. 5-HT and the immune system. Curr Opin Pharmacol. 2011; 11:29-33.
33. Kvachnina E, Liu G, Dityatev A, et al. 5-HT7 receptor is coupled to G alpha subunits of heterotrimeric G12-protein to regulate gene transcription and neuronal morphology. J Neurosci. 2005;25:7821-7830.
34. 7R/G12 signaling regulates neuronal morphology and function in an age-dependent manner. J Neurosci. 2012;32:2915-2930.
35. 12 drives invasion of oral squamous cell carcinoma through up-regulation of proinflammatory cytokines. PLoS One. 2013;8:e66133.
36. Gavard J, Gutkind JS. Protein kinase C-related kinase and ROCK are required for thrombin-induced endothelial cell permeability downstream from Galpha12/13 and Galpha11/q. J Biol Chem. 2008;283:29888-29896.
37. Wójciak-Stothard B, Potempa S, Eichholtz T, et al. Rho and Rac but not Cdc42 regulate endothelial cell permeability. J Cell Sci. 2001;114:1343-1355.
38. O'Connell PJ, Wang X, Leon-Ponte M, et al. A novel form of immune signaling revealed by transmission of the inflammatory mediator serotonin between dendritic cells and T cells. Blood. 2006;107:1010-1017.
39. Kim JJ, Bridle BW, Ghia JE, et al. Targeted inhibition of serotonin type 7 (5-HT7) receptor function modulates immune responses and reduces the severity of intestinal inflammation. J Immunol. 2013;190:4795-4804.
40. Hagan JJ, Price GW, Jeffrey P, et al. Characterization of SB-269970-A, a selective 5-HT(7) receptor antagonist. Br J Pharmacol. 2000;130:539-548.
41. Guscott MR, Egan E, Cook GP, et al. The hypothermic effect of 5-CT in mice is mediated through the 5-HT7 receptor. Neuropharmacology. 2003; 44:1031-1037.
42. Reddy SN, Bazzocchi S, Chan S, et al. Colonic motility and transit in health and ulcerative colitis. Gastroenterology. 1991;101:1289-1297.
43. Mourelle M, Casellas F, Guarner F, et al. Induction of nitric oxide synthase in colonic smooth muscle from patients with toxic megacolon. Gastroenterology. 1995;109:1497-1502.
44. Pouzet B. SB-258741: a 5-HT7 receptor antagonist of potential clinical interest. CNS Drug Rev. 2002;8:90-100.
45. Reddymasu SC, Soykan I, McCallum RW. Domperidone: review of pharmacology and clinical applications in gastroenterology. Am J Gastroenterol. 2007;102:2036-2045.
46. Podolsky DK. Inflammatory bowel disease. N Engl J Med. 2002;347: 417-429.
47. Tlaskalova-Hogenova H, Stepankova R, Hudcovic T, et al. Commensal bacteria (normal microflora), mucosal immunity and chronic inflammatory and autoimmune diseases. Immunol Lett. 2004;93:97-108.
48. Tlaskalova-Hogenova H, Stepankova R, Kozakova H, et al. The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: contribution of germ-free and gnotobiotic animal models of human diseases. Cell Mol Immunol. 2011;8:110-120.
49. Turner JR. Intestinal mucosal barrier function in health and disease. Nat Rev Immunol. 2009;9:799-809.
50. Rath HC, Schultz M, Freitag R, et al. Different subsets of enteric bacteria induce and perpetuate experimental colitis in rats and mice. Infect Immun. 2001;69:2277-2285.
51. Elson CO. Experimental models of intestinal inflammation: new insights into mechanisms of mucosal homeostasis. In: Ogra PL, Mestecky J, Lamm ME, et al, eds. Mucosal Immunology. 2nd ed. San Diego, CA: Academic Press; 1999:1007-1024.
52. Bristol IJ, Farmer MA, Cong Y, et al. Heritable susceptibility for colitis in mice induced by IL-10 deficiency. Inflamm Bowel Dis. 2000;6:290-302.
53. Mähler M, Leiter EH. Genetic and environmental context determines the course of colitis developing in IL-10-deficient mice. Inflamm Bowel Dis. 2002;8:347-355.
54. Bleich A, Mähler M, Most C, et al. Refined histopathologic scoring system improves power to detect colitis QTL in mice. Mamm Genome. 2004; 15:865-871.
55. de las Casas-Engel M, Domínguez-Soto A, Sierra-Filardi E, et al. Serotonin skews human macrophage polarization through HTR2B and HTR7. J Immunol. 2013;190:2301-2310.
56. Steinman RM. The dendritic cell system and its role in immunogenicity. Annu Rev Immunol. 1991;9:271-296.